All our latest news

  • News
    April 30, 2023

    Introduction: Meet the New CEO of Crux Biolabs

    Discover the vision and goals of Crux Biolabs' new CEO in our in-depth interview. Learn about their background in the pharmaceutical industry and the company's plans for expanding bioanalytical services in Australia's R&D landscape.
    Read more
  • News
    March 9, 2023

    MesoScale Discovery (MSD) assays at Crux Biolabs

    MesoScale Discovery (MSD) immunoassays are used to measure the concentration of proteins or other molecules in biological samples. They detect multiple analytes in a single sample and are superior to Luminex because of a wider dynamic range, reduce matrix effects and increase sensitivity. MSD assays…
    Read more
  • News
    February 20, 2023

    The importance of Good Clinical Practice

    When it comes to clinical trials, it is all about the patient! Good Clinical Practice – or GCP as it is known - is a must for biolabs to ensure that their clinical trials are conducted ethically and scientifically. This…
    Read more
  • News
    January 16, 2023

    More on the Australian advantage: up to 43.5% cash back for every $1 spent on R&D in Australia

    When it comes to places to conduct research, few places globally offer better incentives than Australia. Known as the “Australian advantage”, not only does the land down under offer a fast and pragmatic regulatory environment for clinical studies (with a…
    Read more
  • News
    January 16, 2023

    21 colour flow cytometry with Crux Biolabs

    As so many of our partners have thrilled since earlier in the year when we launched our capability to provide 21 colour flow cytometry, we just had to do a shout out to it. As you no doubt know, flow…
    Read more
  • News
    December 16, 2022

    Crux Biolabs: expansion into chemistry

    After repeated inquiries from our customer base, Crux Biolabs are pleased to announce their expansion into chemistry analytical services in 2023. These services will be centred around UHPLC and LCMS instrumentation to be installed in our new, purpose-built lab space.…
    Read more
  • News
    October 15, 2022

    Join us at: AusBiotech 2022

    We are pleased to be attending AusBiotech 2022 in Perth! If you are also attending this year's event, get in touch with any of our team here as we would love to connect and get to know you better.
    Read more
  • News
    August 4, 2022

    Media Release: Genesis Capital invests in Crux Biolabs

    Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector  Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology…
    Read more
  • News
    June 29, 2022

    External Quality Assurance Programs

    Crux Biolabs has recently passed 2 External Quality Assurance Programs (EQAPs) and we’d like to congratulate the fantastic scientists involved. Livleen Kaur successfully passed Crux’s 2nd consecutive participation in the international Duke University EQAPOL for Luminex with a staggering score…
    Read more
  • Available Positions, News
    June 1, 2022

    Senior Immunology Scientist hiring (flow cytometry)

    We're hiring again! Are you a gun at flow cytometry?Are you sick of short-term academic contracts?Maybe you could be Crux's Senior Immunology Scientist, a newly created permanent position, in our growing contract research team to work on cutting-edge immunotherapy clinical…
    Read more